We also showed, in this study, that histone deacetylation and DNA methylation inhibitors upregulated IL-13Rα2 in prostate cancer cells, and went further to determine whether this would enhance the sensitivity of the cells to Pep-1-Phor21. Here, IL13RA2 is linked to prostate cancer.